LORATADINE TABLETS USP, 10 MG

LORATADINE TABLETS USP, 10 MG was reported 45 times

LORATADINE TABLETS USP, 10 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OESOPHAGEAL MUCOSAL TEAR 1 0.0303
1 GASTRIC VARICES HAEMORRHAGE 1 0.0030
2 CIRCUMORAL OEDEMA 1 0.0029
3 IMPLANT SITE IRRITATION 1 0.0026
4 UMBILICAL CORD ABNORMALITY 1 0.0019
5 KLEBSIELLA TEST POSITIVE 1 0.0015
6 DIAPHRAGMATIC DISORDER 1 0.0013
7 SCIATIC NERVE INJURY 1 0.0012
8 SYNDACTYLY 1 0.0012
9 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
10 CULTURE URINE POSITIVE 1 0.0007
11 MULTIPLE CONGENITAL ABNORMALITIES 1 0.0007
12 STARING 1 0.0004
13 BRONCHITIS CHRONIC 1 0.0004
14 DRUG TITRATION ERROR 1 0.0004
15 PROCEDURAL COMPLICATION 2 0.0003
16 PNEUMONIA ASPIRATION 5 0.0002
17 NYSTAGMUS 1 0.0002
18 PRODUCT SIZE ISSUE 1 0.0002
19 DYSGRAPHIA 1 0.0002
20 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
21 SQUAMOUS CELL CARCINOMA 1 0.0001
22 COMA 5 0.0001
23 PARAESTHESIA ORAL 1 0.0001
24 CYANOSIS 1 0.0001
25 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
26 EOSINOPHILIA 1 0.0001
27 PREGNANCY 1 0.0000
28 PRODUCT PHYSICAL ISSUE 1 0.0000
29 FEEDING DISORDER 1 0.0000
30 IRRITABLE BOWEL SYNDROME 1 0.0000
31 RECTAL HAEMORRHAGE 2 0.0000
32 RASH MACULO-PAPULAR 1 0.0000
33 PANCREATITIS ACUTE 1 0.0000
34 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
35 HAEMATOMA 1 0.0000
36 JOINT STIFFNESS 1 0.0000
37 TARDIVE DYSKINESIA 1 0.0000
38 ACUTE MYOCARDIAL INFARCTION 1 0.0000
39 APHASIA 1 0.0000
40 SWOLLEN TONGUE 1 0.0000
41 CYSTITIS 1 0.0000
42 FUNGAL INFECTION 1 0.0000
43 HYPOXIA 1 0.0000
44 LYMPHADENOPATHY 1 0.0000
45 PANIC ATTACK 1 0.0000
46 DISORIENTATION 1 0.0000
47 SOMNOLENCE 5 0.0000
48 DEVICE BREAKAGE 1 0.0000
49 MENTAL DISORDER 1 0.0000
50 ANGIOEDEMA 1 0.0000
51 THROAT IRRITATION 1 0.0000
52 RENAL DISORDER 1 0.0000
53 OCULAR HYPERAEMIA 1 0.0000
54 BRADYCARDIA 1 0.0000
55 DISTURBANCE IN ATTENTION 1 0.0000
56 HAEMATOCHEZIA 1 0.0000
57 OXYGEN SATURATION DECREASED 1 0.0000
58 PRODUCT SUBSTITUTION ISSUE 1 0.0000
59 CATARACT 1 0.0000
60 ILL-DEFINED DISORDER 1 0.0000
61 EXPOSURE DURING PREGNANCY 1 0.0000
62 RHINORRHOEA 1 0.0000
63 INFUSION RELATED REACTION 1 0.0000
64 BURNING SENSATION 1 0.0000
65 INJURY 1 0.0000
66 AGITATION 1 0.0000
67 CARDIAC ARREST 1 0.0000
68 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
69 URTICARIA 2 0.0000
70 OROPHARYNGEAL PAIN 1 0.0000
71 COUGH 3 0.0000
72 SWELLING 1 0.0000
73 DYSPHAGIA 1 0.0000
74 HAEMOGLOBIN DECREASED 1 0.0000
75 ASTHMA 1 0.0000
76 SEIZURE 1 0.0000
77 LOSS OF CONSCIOUSNESS 1 0.0000
78 HYPERHIDROSIS 1 0.0000
79 PARAESTHESIA 1 0.0000
80 CONFUSIONAL STATE 1 0.0000
81 ABDOMINAL DISCOMFORT 1 0.0000
82 CEREBROVASCULAR ACCIDENT 1 0.0000
83 URINARY TRACT INFECTION 1 0.0000
84 PYREXIA 2 0.0000
85 BLOOD GLUCOSE INCREASED 1 0.0000
86 GAIT DISTURBANCE 1 0.0000
87 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
88 PAIN 3 0.0000
89 ABDOMINAL PAIN UPPER 1 0.0000
90 CONSTIPATION 1 0.0000
91 MALAISE 2 0.0000
92 INCORRECT DOSE ADMINISTERED 1 0.0000
93 BACK PAIN 1 0.0000
94 ABDOMINAL PAIN 1 0.0000
95 VOMITING 2 0.0000
96 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
97 FATIGUE 3 0.0000
98 DRUG INEFFECTIVE 5 0.0000
99 INJECTION SITE PAIN 1 0.0000
100 HEADACHE 2 0.0000
101 ASTHENIA 1 0.0000
102 PRURITUS 1 0.0000
103 RASH 1 0.0000
104 DIZZINESS 1 0.0000
105 DYSPNOEA 1 0.0000
106 DIARRHOEA 1 0.0000
107 NAUSEA 1 0.0000
108 DEATH 1 0.0000